Market Research
U.S. Legal Cannabis Sales Hit $2.3B in December, Lifting 2025 Total to $27B
LOS ANGELES – Legal Cannabis sales across the United States ...
Portugal Medical Cannabis Outpaces 2025 Export Run Rate
LISBON – Portugal's medicines regulator, Infarmed, has confirmed that the ...
UMiami Hands Over Its 1994 Ibogaine Research to Washington
LOS ANGELES – The University of Miami has donated its ...
Hemp-Derived THC Beverages Gain Traction as U.S. Alcohol Consumption Declines
LOS ANGELES – Hemp-derived THC beverages generated $382 million in sales in 2024, a marked increase from previous years, yet 2025 projections indicate tempered growth at $571 million, climbing to $756 million by 2029 with ...
Cannabis MSOs Face High-Stakes Tax Dilemma as Rescheduling Decision Looms Under Trump
As Trump's administration weighs reclassifying Cannabis to Schedule III, Cannabis giants continue to contend with hefty uncertain tax liabilities under IRS Section 280E, a rule that has long hampered their financial flexibility. A recent report ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...
Earnings Season: Cannabis Operators Deliver a Different Kind of Q2 2026
LOS ANGELES – The Cannabis industry wraps up its second-quarter earnings, and the aggregate picture carries a theme that would have been harder to locate a few years ago. Operators are making money. Profitability, not ...
